RBC Capital Downgrades Pactiv Evergreen(PTVE.US) to Hold Rating, Raises Target Price to $18
RBC Downgrades Pactiv Evergreen to Sector Perform From Outperform, Raises Price Target to $18 From $14
Jefferies Downgrades Pactiv Evergreen(PTVE.US) to Hold Rating, Raises Target Price to $18
Pactiv Evergreen Analyst Ratings
Baird Maintains Pactiv Evergreen(PTVE.US) With Hold Rating, Raises Target Price to $18
Citi Downgrades Pactiv Evergreen(PTVE.US) to Hold Rating, Raises Target Price to $18
Pactiv Evergreen: Buy Rating Amid Growth Potential and Market Underestimation
Jefferies Maintains Pactiv Evergreen(PTVE.US) With Buy Rating, Cuts Target Price to $15
Jefferies Remains a Buy on Pactiv Evergreen (PTVE)
Baird Maintains Pactiv Evergreen(PTVE.US) With Hold Rating, Maintains Target Price $12
Pactiv Evergreen's Strategic Transition: Hold Rating Amid Operational Challenges and Future Growth Potential
BofA Securities Maintains Pactiv Evergreen(PTVE.US) With Buy Rating, Raises Target Price to $17
RBC Capital Maintains Pactiv Evergreen(PTVE.US) With Buy Rating, Raises Target Price to $14
RBC Capital Maintains Pactiv Evergreen(PTVE.US) With Buy Rating, Maintains Target Price $13
Pactiv Evergreen (PTVE) Receives a Buy From RBC Capital
UBS Trims Price Target on Pactiv Evergreen to $15 From $16, Maintains Buy Rating
Pactiv Evergreen Analyst Ratings
RBC Capital Maintains Outperform on Pactiv Evergreen, Lowers Price Target to $13
Pactiv Evergreen (PTVE) Gets a Buy From RBC Capital
Pactiv Evergreen Analyst Ratings